By developing an integration with Eversense 365, SweetSpot can work alongside practices to act on this unique system’s CGM data in between patients’ scheduled appointments, allowing for more ...

Senseonics and Ascensia's integration enhances diabetes management through SweetSpot's software and Eversense 365 CGM system for better patient care. Senseonics Holdings, Inc. and Ascensia ...

Senseonics (SENS) and Ascensia Diabetes Care announce the software integration of SweetSpot with the Eversense 365 Continuous Glucose Monitoring, CGM, System in the U.S. This software integration ...

Senseonics Holdings, Inc. announced the FDA approval and U.S. launch of its Eversense® 365 Continuous Glucose Monitoring (CGM) system in 2024, which has led to a 56% increase in its global ...

One CGM, with the Eversense 365 CGM system. The feedback we have received from patients and providers has been very positive, and we are just getting started. We see our 365 day product as the ...

Highlights,FDA approval and US launch of Eversense® 365 CGM system drives 56% patient base growth.,Q4 2024 revenue reached $8.3 million, with a net loss of $15.5 million.,Senseonics projects $34-38 ...

Senseonics and Ascensia integrate software between SweetSpot and Eversense 365, the world’s first and only One Year CGM system SweetSpot partners with endocrinology practices to provide virtual ...

and PARSIPPANY, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE: SENS) and Ascensia Diabetes Care announce the software integration of SweetSpot™ with the Eversense ® 365 ...

Senseonics and Ascensia integrate software between SweetSpot and Eversense 365, the world’s first and only One Year CGM system SweetSpot partners with endocrinology practices to provide virtual CGM ...